IMP-43 and IMP-44 metallo-β-lactamases with increased carbapenemase activities in multidrug-resistant Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 9, 2013, Pages 4427-4432

  Tada, Tatsuya ^a   Miyoshi Akiyama, Tohru ^a   Shimada, Kayo ^a   Shimojima, Masahiro ^b   Kirikae, Teruo ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b Kawagoe shi   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CARBAPENEM DERIVATIVE; CARBAPENEMASE; DORIPENEM; IMIPENEM; INOSINE PHOSPHATE; INOSINE PHOSPHATE 11; INOSINE PHOSPHATE 43; INOSINE PHOSPHATE 44; INOSINE PHOSPHATE 7; MEROPENEM; METALLO BETA LACTAMASE; PHE87SER; UNCLASSIFIED DRUG; VAL67PHE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BACTERIUM ISOLATE; ENZYME ACTIVITY; ESCHERICHIA COLI; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARBAPENEMS; CATALYTIC DOMAIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; IMIPENEM; JAPAN; PHYLOGENY; PLASMIDS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; STRUCTURE-ACTIVITY RELATIONSHIP; THIENAMYCINS;

EID: 84882292756     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00716-13     Document Type: Article

References (39)

1. Bush K. 2001. New beta-lactamases in Gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin. Infect. Dis. 32:1085-1089.
2. Walsh TR, Toleman MA, Poirel L, Nordmann P. 2005. Metallo-betalactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306-325.
3. Bush K, Jacoby GA. 2010. Updated functional classification of betalactamases. Antimicrob. Agents Chemother. 54:969-976.
4. Cornaglia G, Giamarellou H, Rossolini GM. 2011. Metallo-betalactamases: a last frontier for beta-lactams? Lancet Infect. Dis. 11:381-393.
5. Yong D, Toleman MA, Bell J, Ritchie B, Pratt R, Ryley H, Walsh TR. 2012. Genetic and biochemical characterization of an acquired subgroup B3 metallo-beta-lactamase gene, blaAIM-1, and its unique genetic context in Pseudomonas aeruginosa from Australia. Antimicrob. Agents Chemother. 56:6154-6159.
6. Rogalski TM, Gilbert MM, Devenport D, Norman KR, Moerman DG. 2003. DIM-1, a novel immunoglobulin superfamily protein in Caenorhabditis elegans, is necessary for maintaining bodywall muscle integrity. Genetics 163:905-915.
7. Pollini S, Maradei S, Pecile P, Olivo G, Luzzaro F, Docquier JD, Rossolini GM. 2013. FIM-1, a new acquired metallo-beta-lactamase from a Pseudomonas aeruginosa clinical isolate from Italy. Antimicrob. Agents Chemother. 57:410-416.
8. Castanheira M, Toleman MA, Jones RN, Schmidt FJ, Walsh TR. 2004. Molecular characterization of a beta-lactamase gene, blaGIM-1, encoding a new subclass of metallo-beta-lactamase. Antimicrob. Agents Chemother. 48:4654-4661.
9. Osano E, Arakawa Y, Wacharotayankun R, Ohta M, Horii T, Ito H, Yoshimura F, Kato N. 1994. Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob. Agents Chemother. 38:71-78.
10. Sekiguchi J, Morita K, Kitao T, Watanabe N, Okazaki M, Miyoshi-Akiyama T, Kanamori M, Kirikae T. 2008. KHM-1, a novel plasmidmediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate. Antimicrob. Agents Chemother. 52:4194-4197.
11. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR. 2009. Characterization of a new metallo-beta-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53:5046-5054.
12. Wachino J, Yoshida H, Yamane K, Suzuki S, Matsui M, Yamagishi T, Tsutsui A, Konda T, Shibayama K, Arakawa Y. 2011. SMB-1, a novel subclass B3 metallo-beta-lactamase, associated with ISCR1 and a class 1 integron, from a carbapenem-resistant Serratia marcescens clinical isolate. Antimicrob. Agents Chemother. 55:5143-5149.
13. Lee K, Yum JH, Yong D, Lee HM, Kim HD, Docquier JD, Rossolini GM, Chong Y. 2005. Novel acquired metallo-beta-lactamase gene, blaSIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob. Agents Chemother. 49:4485-4491.
14. Zavascki AP, Gaspareto PB, Martins AF, Goncalves AL, Barth AL. 2005. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-beta-lactamase in a teaching hospital in southern Brazil. J. Antimicrob. Chemother. 56:1148-1151.
15. El Salabi A, Borra PS, Toleman MA, Samuelsen O, Walsh TR. 2012. Genetic and biochemical characterization of a novel metallo-betalactamase, TMB-1, from an Achromobacter xylosoxidans strain isolated in Tripoli, Libya. Antimicrob. Agents Chemother. 56:2241-2245.
16. Lauretti L, Riccio ML, Mazzariol A, Cornaglia G, Amicosante G, Fontana R, Rossolini GM. 1999. Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob. Agents Chemother. 43:1584-1590.
17. Jacoby GA, Munoz-Price LS. 2005. The new beta-lactamases. N. Engl. J. Med. 352:380-391.
18. Hamada Y, Watanabe K, Tatsuya T, Mezaki K, Takeuchi S, Shimizu T, Kirikae T, Ohmagari N. 2012. Three cases of IMP-type metallo-betalactamase-producing Enterobacter cloacae bloodstream infection in Japan. J. Infect. Chemother. doi:10.1007/s10156-012-0520-6.
19. Clinical and Laboratory Standards Institute. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 9th ed. Approved standard M07-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
20. Kitao T, Miyoshi-Akiyama T, Tanaka M, Narahara K, Shimojima M, Kirikae T. 2011. Development of an immunochromatographic assay for diagnosing the production of IMP-type metallo-beta-lactamases that mediate carbapenem resistance in Pseudomonas. J. Microbiol. Methods. 87: 330-337.
21. Sekiguchi J, Asagi T, Miyoshi-Akiyama T, Kasai A, Mizuguchi Y, Araake M, Fujino T, Kikuchi H, Sasaki S, Watari H, Kojima T, Miki H, Kanemitsu K, Kunishima H, Kikuchi Y, Kaku M, Yoshikura H, Kuratsuji T, Kirikae T. 2007. Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan. J. Clin. Microbiol. 45:979-989.
22. Boschi L, Mercuri PS, Riccio ML, Amicosante G, Galleni M, Frere JM, Rossolini GM. 2000. The Legionella (Fluoribacter) gormanii metallo- betalactamase: a new member of the highly divergent lineage of molecularsubclass B3 beta-lactamases. Antimicrob. Agents Chemother. 44:1538-1543.
23. Crowder MW, Walsh TR, Banovic L, Pettit M, Spencer J. 1998. Overexpression, purification, and characterization of the cloned metallo-betalactamase L1 from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 42:921-926.
24. Queenan AM, Shang W, Flamm R, Bush K. 2010. Hydrolysis and inhibition profiles of beta-lactamases from molecular classes A to D with doripenem, imipenem, and meropenem. Antimicrob. Agents Chemother. 54:565-569.
25. Llanes C, Hocquet D, Vogne C, Benali-Baitich D, Neuwirth C, Plesiat P. 2004. Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously. Antimicrob. Agents Chemother. 48:1797-1802.
26. Pagani L, Colinon C, Migliavacca R, Labonia M, Docquier JD, Nucleo E, Spalla M, Li Bergoli M, Rossolini GM. 2005. Nosocomial outbreak caused by multidrug-resistant Pseudomonas aeruginosa producing IMP-13 metallo-beta- lactamase. J. Clin. Microbiol. 43:3824-3828.
27. Hrabak J, Cervena D, Izdebski R, Duljasz W, Gniadkowski M, Fridrichova M, Urbaskova P, Zemlickova H. 2011. Regional spread of Pseudomonas aeruginosa ST357 producing IMP-7 metallo-beta-lactamase in Central Europe. J. Clin. Microbiol. 49:474-475.
28. Moali C, Anne C, Lamotte-Brasseur J, Groslambert S, Devreese B, Van Beeumen J, Galleni M, Frere JM. 2003. Analysis of the importance of the metallo-beta-lactamase active site loop in substrate binding and catalysis. Chem. Biol. 10:319-329.
29. Prosperi-Meys C, Wouters J, Galleni M, Lamotte-Brasseur J. 2001. Substrate binding and catalytic mechanism of class B beta-lactamases: a molecular modelling study. Cell. Mol. Life Sci. 58:2136-2143.
30. Borgianni L, Vandenameele J, Matagne A, Bini L, Bonomo RA, Frere JM, Rossolini GM, Docquier JD. 2010. Mutational analysis of VIM-2 reveals an essential determinant for metallo-beta-lactamase stability and folding. Antimicrob. Agents Chemother. 54:3197-3204.
31. Docquier JD, Lamotte-Brasseur J, Galleni M, Amicosante G, Frere JM, Rossolini GM. 2003. On functional and structural heterogeneity of VIMtype metallo-beta-lactamases. J. Antimicrob. Chemother. 51:257-266.
32. Jacoby GA. 2009. AmpC beta-lactamases. Clin. Microbiol. Rev. 22:161-182.
33. Schweizer HP. 2003. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet. Mol. Res. 2:48-62.
34. Masuda N, Sakagawa E, Ohya S, Gotoh N, Tsujimoto H, Nishino T. 2000. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44:3322-3327.
35. Gibb AP, Tribuddharat C, Moore RA, Louie TJ, Krulicki W, Livermore DM, Palepou MF, Woodford N. 2002. Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new blaIMP allele, bla(IMP-7). Antimicrob. Agents Chemother. 46:255-258.
36. Hrabak J, Fridrichova M, Stolbova M, Bergerova T, Zemlickova H, Urbaskova P. 2009. First identification of metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Czech Republic. Euro Surveill. 14:19102.
37. Kouda S, Kuwahara R, Ohara M, Shigeta M, Fujiwara T, Komatsuzawa H, Usui T, Sugai M. 2007. First isolation of blaIMP-7 in a Pseudomonas aeruginosa in Japan. J. Infect. Chemother. 13:276-277.
38. Ho SE, Subramaniam G, Palasubramaniam S, Navaratnam P. 2002. Carbapenem-resistant Pseudomonas aeruginosa in Malaysia producing IMP-7 beta-lactamase. Antimicrob. Agents Chemother. 46:3286-3287.
39. Ohlasova D, Kmet V, Niks M. 2007. First report of the carbapenemresistant Pseudomonas aeruginosa producing IMP-7 metallo-betalactamase in Slovakia. Int. J. Antimicrob. Agents. 30:370-371.